GleamWall
中文EN

HELP Helus Pharma Inc. IFRS Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1833141 · Reporting currency CAD · Fiscal year ends 03/31

Financial factors as of 2025-03-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-44.9%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-42.8%
ROA-40.4%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets8.3%
Debt / equity0.00x
Current ratio7.75x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-4.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2025*2025-03-31FY2024*2024-03-31
Income statement
Revenue——
R&D expense54.91M32.36M
SG&A expense45.37M32.59M
Income tax00
Net income-113.14M-78.08M
EPS (basic)-5.59-9.41
EPS (diluted)——
Balance sheet
Cash & equivalents135.02M208.99M
Receivables5.88M4.48M
Current assets165.97M218.54M
PP&E, netmay include right-of-use assets (IFRS)141,000266,000
Goodwill51.49M47.48M
Intangibles41.02M35.47M
Total assets258.62M302.02M
Current liabilities21.42M10.10M
Total liabilities21.42M10.10M
Shareholders' equity237.20M291.93M
Cash flow statement
Operating cash flow-101.30M-68.91M
Capital expenditure—21,000
Free cash flow—-68.93M
Investing cash flow-1.97M6.92M
Financing cash flow20.20M254.51M
Depreciation & amortization475,000424,000
Stock-based compensation42.87M13.89M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.